Notable Analyst Rating Changes 05/10: (TPX) (PRU) (KERX) Upgraded; (VRTX) (HGSI) (ORCL) Downgraded May 10, 2012 11:20AM
Notable Analyst Rating Changes 08/23: (JNPR) (NVDA) (JASO) Upgraded; (STP) (WAG) (PEG) Downgraded Aug 23, 2011 10:58AM
Human Genome (HGSI) volatility low at 73 after announcing positive data Nov 3, 2009 08:49AM
Notable Analyst Rating Changes 8/4: HBC, HGSI, PKY, DISH, TLB Upgraded; HOLX, ATML, ABX, STEC, LAMR Downgraded Aug 4, 2009 10:26AM
Human Genome Sciences (HGSI): Upgraded to Buy at ThinkEquity; target raised to $26 (new Street high) Aug 4, 2009 07:44AM


Aug 4, 2009 07:31AM ThinkEquity Upgrades Human Genome Sciences (HGSI) to Buy
Jul 21, 2009 12:59PM Analysts Still Jumping on Human Genome Sciences (HGSI) Bandwagon: 3 Upgrades Today
Jul 21, 2009 12:27PM Unusual 11 Mid-Day Movers 7/21: MNOV, JRN, JDAS, BCRX Higher; CIT, IDIX, STSA, LXK Lower
Jun 12, 2009 09:45AM Notable Analyst Rating Changes 6/12: SKS, CSX, SNIC, PBR Upgraded; AKS, ERIC, TWTC, HGSI Downgraded
Jun 5, 2009 08:47AM ThinkEquity Downgrades Human Genome Sciences (HGSI) to Source of Funds